Literature DB >> 15019493

Inflammatory effects of snake venom myotoxic phospholipases A2.

C F P Teixeira1, E C T Landucci, E Antunes, M Chacur, Y Cury.   

Abstract

Snake venom phospholipases A2 (PLA2) show a remarkable functional diversity. Among their toxic activities, some display the ability to cause rapid necrosis of skeletal muscle fibers, thus being myotoxic PLA2s. Besides myotoxicity, these enzymes evoke conspicuous inflammatory and nociceptive events in experimental models. Local inflammation and pain are important characteristics of snakebite envenomations inflicted by viperid and crotalid species, whose venoms are rich sources of myotoxic PLA2s. Since the discovery that mammalian PLA2 is a key enzyme in the release of arachidonic acid, the substrate for the synthesis of several lipid inflammatory mediators, much interest has been focused on this enzyme in the context of inflammation. The mechanisms involved in the proinflammatory action of secretory PLA2s are being actively investigated, and part of the knowledge on secretory PLA2 effects has been gained by using snake venom PLA2s as tools, due to their high structural homology with human secretory PLA2s. The inflammatory events evoked by PLA2s are primarily associated with enzymatic activity and to the release of arachidonic acid metabolites. However, catalytically inactive Lys49 PLA2s trigger inflammatory and nociceptive responses comparable to those of their catalytically active counterparts, thereby evidencing that these proteins promote inflammation and pain by mechanisms not related to phospholipid hydrolysis nor to mobilization of arachidonic acid. These studies have provided a boost to the research in this field and various approaches have been used to identify the amino acid residues and the specific sites of interaction of myotoxic PLA2s with cell membranes potentially involved in the PLA2-induced inflammatory and nociceptive effects. This work reviews the proinflammatory and nociceptive effects evoked by myotoxic PLA2s and their mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15019493     DOI: 10.1016/j.toxicon.2003.11.006

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  60 in total

1.  Inhibitory effects of bile acids on enzymatic and pharmacological activities of a snake venom phospholipase A(2) from group IIA.

Authors:  Jaime Andrés Pereañez; Vitelbina Núñez; Arley Camilo Patiño
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

2.  Viper venom-induced oxidative stress and activation of inflammatory cytokines: a therapeutic approach for overlooked issues of snakebite management.

Authors:  M Sebastin Santhosh; M Shanmuga Sundaram; K Sunitha; K Kemparaju; K S Girish
Journal:  Inflamm Res       Date:  2013-05-09       Impact factor: 4.575

3.  Conodipine-P1-3, the First Phospholipases A2 Characterized from Injected Cone Snail Venom.

Authors:  Carolina Möller; W Clay Davis; Evan Clark; Anthony DeCaprio; Frank Marí
Journal:  Mol Cell Proteomics       Date:  2019-02-14       Impact factor: 5.911

4.  Effects of photobiostimulation on edema and hemorrhage induced by Bothrops moojeni venom.

Authors:  Nikele Nadur-Andrade; Ana Maria Barbosa; Fernando Pereira Carlos; Carlos José Lima; José Carlos Cogo; Stella Regina Zamuner
Journal:  Lasers Med Sci       Date:  2011-04-12       Impact factor: 3.161

5.  Inhibition of secretory phospholipase A(2) enzyme by bilirubin: a new role as endogenous anti-inflammatory molecule.

Authors:  Noor Mohamed Jameel; Brigitte M Frey; Felix J Frey; T Veerabasappa Gowda; Bannikuppe S Vishwanath
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

6.  Crotalus helleri venom preconditioning reduces postoperative cerebral edema and improves neurological outcomes after surgical brain injury.

Authors:  Cherine H Kim; Devin W McBride; Prativa Sherchan; Carl E Person; Eric C K Gren; Wayne Kelln; Tim Lekic; William K Hayes; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2017-03-09       Impact factor: 5.996

7.  Nonbactericidal secreted phospholipase A2s are potential anti-inflammatory factors in the mammary gland.

Authors:  Eyal Seroussi; Shelly Klompus; Maayan Silanikove; Oleg Krifucks; Fira Shapiro; Arieh Gertler; Gabriel Leitner
Journal:  Immunogenetics       Date:  2013-10-03       Impact factor: 2.846

8.  Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

Authors:  Nilda M Muñoz; Angelo Y Meliton; Lucille N Meliton; Steven M Dudek; Alan R Leff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

9.  Pharmacological study of edema and myonecrosis in mice induced by venom of the bushmaster snake (Lachesis muta muta) and its basic Asp49 phospholipase A(2) (LmTX-I).

Authors:  Daniela C S Damico; Maria Alice da Cruz Höfling; Mariana Cintra; Marta B Leonardo; Andrana K Calgarotto; Saulo L da Silva; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

10.  Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Shao-Heng He
Journal:  BMC Immunol       Date:  2009-04-28       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.